CJC-1295 Stimulates GH and IGF-1 Secretion and will keep a steady increase of HGH and IGF-1 with no increase in prolactin.
It increases protein synthesis and stimulates the growth of new muscle tissue. It also increases muscle mass (and physical strength if combined with moderate exercise) reduces wrinkling of the skin and reverses other effects of skin aging. As well as causing hyperplasia, the increase of more muscle cells. CJC-1295 promotes lipolysis, which results in the reduction of adipose tissue (body fat).
Modified GRF (1-29)
Modified GRF 1-29 (GHRH) CJC1295 Growth Hormone Releasing Hormone (GHRH) CJC-1295 is a synthetic secretagogue which stimulates HGH release. In the human body, large amounts of growth hormones are stored in the pituitary. GHRH affects the number of secreting cells and the amount they are able to secrete. Modified GRF 1-29 was invented by ConjuChem, a Canadian biotechnology company. It has a very short acting half-life of about 30 minutes. It is a modified version of the shortest fully functional fragment of Growth-hormone-releasing hormone often referred to as Growth Hormone Releasing Factor (1-29) abbreviated as (GRF (1-29)) also known by its pharmaceutical name Sermorelin™.